Current status of therapeutic plasma exchange in Korea

被引:8
作者
Song, EY
Kwon, SW
Kim, DS
Kim, DW
Kim, DW
Kim, HO
Park, CW
Suh, JS
Ryang, DW
Lee, JN
Lee, JW
Lim, YA
Lim, CS
Jeon, DS
Han, CW
Han, TH
Han, KS
机构
[1] Seoul Natl Univ, Coll Med, Dept Lab Med, Seoul 110744, South Korea
[2] Univ Ulsan, Coll Med, Ulsan 680749, South Korea
[3] Inje Univ, Coll Med, Pusan, South Korea
[4] Univ Korea Hosp, Seoul, South Korea
关键词
Korea; plasma exchange; registry; therapeutic apheresis;
D O I
10.1111/j.1526-0968.2003.00111.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A nationwide survey on the status of plasma exchange in Korea was performed during the 2 year period 2001-02. Data from 496 patients were collected from 15 major hospitals. ne most common indication was myasthenia gravis (15.3%), followed by thrombotic thrombocytopenic purpura (14.5%) and hemolytic uremic syndrome (9.7%). Clinical improvement was noted in 70.1% of the 415 cases. Plasma exchange by centrifugation alone accounted for 92.4%. Postcentrifugal filtration was carried out in 5.6% and double filtration in 2.0% of treatments. The most common instruments for the centrifugation were Cobe Spectra (71.3%) and Fenwal CS3000 (15.8%). Filtration was performed by either Kuraray KM8300 or Kuraray KM8800. The overall frequency of complications was 11.1% (293/2647 cases), of which symptomatic hypocalcemia was the most common (2.3%).
引用
收藏
页码:97 / 101
页数:5
相关论文
共 16 条
[1]   COMPLICATIONS OF THERAPEUTIC PLASMA-EXCHANGE - A RECENT ASSESSMENT [J].
COURIEL, D ;
WEINSTEIN, R .
JOURNAL OF CLINICAL APHERESIS, 1994, 9 (01) :1-5
[2]  
Kaplan AA, 1999, PRACTICAL GUIDE THER
[3]   14 years of therapeutic plasma exchange in France [J].
Korach, JM ;
Petitpas, D ;
Poiron, L ;
Vincent, N ;
Berger, P ;
Chillet, P .
TRANSFUSION AND APHERESIS SCIENCE, 2001, 25 (01) :73-77
[4]   International forum: France the national survey of plasma exchange and therapeutic cytapheresis in France [J].
Korach, JM ;
Bussel, A ;
Gajdos, P .
TRANSFUSION SCIENCE, 1995, 16 (04) :363-370
[5]   Role of replacement fluids in the immediate complications of plasma exchange [J].
Korach, JM ;
Berger, P ;
Giraud, C ;
Le Perff-Desman, C ;
Chillet, P .
INTENSIVE CARE MEDICINE, 1998, 24 (05) :452-458
[6]  
KWON OH, 1993, KOREAN J BLOOD TRANS, V4, P43
[7]   Apheresis technologies and clinical applications: The 2000 International Apheresis Registry [J].
Malchesky, PS ;
Koo, AP ;
Rybicki, LA .
THERAPEUTIC APHERESIS, 2001, 5 (03) :193-203
[8]   THE INTERNATIONAL APHERESIS REGISTRY - RESULTS OF 1983 2ND PILOT [J].
MALCHESKY, PS ;
SKIBINSKI, CI ;
WILLIAMS, GW ;
NOSE, Y .
ARTIFICIAL ORGANS, 1987, 11 (02) :173-182
[9]  
MCLEOD BC, 1997, APHERESIS PRINCIPLES
[10]   Apheresis registry in Sweden: scope, techniques and indications for treatment. A report from the Swedish apheresis study group [J].
Norda, R ;
Stegmayr, BG .
TRANSFUSION AND APHERESIS SCIENCE, 2001, 24 (01) :49-55